Design Expert® supported optimization and predictive analysis of selegiline nanoemulsion via the olfactory region with enhanced behavioural performance in Parkinson's disease

Nanotechnology

Volumn 27, Issue 43, 2016, Pages

  Kumar, Shobhit ^a   Ali, Javed ^a   Baboota, Sanjula ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

behavioural study; central composite rotable design; in vitro release; nanoemulsion; permeation study; selegiline

Indexed keywords

BIOCHEMISTRY; DROPS; DRUG PRODUCTS; MULTIVARIANT ANALYSIS; NEURODEGENERATIVE DISEASES; POLYDISPERSITY; RATS; REFRACTIVE INDEX; TARGETED DRUG DELIVERY; ZETA POTENTIAL;

BEHAVIOURAL STUDIES; CENTRAL COMPOSITE; IN-VITRO; NANOEMULSION; SELEGILINE;

CONTROLLED DRUG DELIVERY;

NANOMATERIAL; SELEGILINE;

ANIMAL; ANIMAL BEHAVIOR; EMULSION; OLFACTORY BULB; PARKINSON DISEASE; RAT; SOLUBILITY; WISTAR RAT;

ANIMALS; BEHAVIOR, ANIMAL; EMULSIONS; NANOSTRUCTURES; OLFACTORY BULB; PARKINSON DISEASE; RATS; RATS, WISTAR; SELEGILINE; SOLUBILITY;

EID: 84989159377     PISSN: 09574484     EISSN: 13616528     Source Type: Journal    
DOI: 10.1088/0957-4484/27/43/435101     Document Type: Article

References (51)

1. Lecht S, Haroutiunian S, Hoffman A and Lazarovici P 2007 Rasagiline - a novel MAO B inhibitor in Parkinson's disease therapy Ther. Clin. Risk Manag. 3 467-74
2. Fang J Y, Hung C F, Chi C H and Chen C C 2009 Transdermal permeation of selegiline from hydrogel-membrane drug delivery systems Int. J. Pharm. 380 33-9
3. Magyar K 2011 The pharmacology of selegiline Int. Rev. Neurobiol. 100 65-84
4. Le Droumaguet B, Souguir H, Brambilla D, Verpillot R, Nicolas J, Taverna M, Couvreur P and Andrieux K 2001 Selegiline-functionalized, PEGylated poly(alkyl cyanoacrylate) nanoparticles: Investigation of interaction with amyloid-β peptide and surface reorganization Int. J. Pharm. 416 453-60
5. Lee K C and Chen J J 2007 Transdermal selegiline for the treatment of major depressive disorder Neuropsychiatr. Dis. Treat. 3 527-37
6. Alam M I, Baboota S, Ahuja A, Ali M, Ali J and Sahni J K 2012 Intranasal administration of nanostructured lipid carriers containing CNS acting drug: pharmacodynamic studies and estimation in blood and brain J. Psychiatr. Res. 46 1133-8
7. Mustafa G, Ahuja A, Al Rohaimi A H, Muslim S, Hassan A A, Baboota S and Ali J 2015 Nano-ropinirole for the management of Parkinsonism: blood-brain pharmacokinetics and carrier localization Expert Rev. Neurother. 15 695-710
8. Fazil M, Md S, Haque S, Kumar M, Baboota S, Sahni J K and Ali J 2012 Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting Eur. J. Pharm. Sci. 47 6-15
9. Md S, Haque S, Fazil M, Kumar M, Baboota S, Sahni J K and Ali J 2014 Optimised nanoformulation of bromocriptine for direct nose-to-brain delivery: biodistribution, pharmacokinetic and dopamine estimation by ultra-HPLC/mass spectrometry method Expert Opin Drug Deliv. 11 827-42
10. Kumar M, Misra A, Babbar A K, Mishra A K, Mishra P and Pathak K 2008 Intranasal nanoemulsion based brain targeting drug delivery system of risperidone Int. J. Pharm. 358 285-91
11. Pangeni R, Sharma S, Mustafa G, Ali J, Baboota S and Vitamin E 2014 Loaded resveratrol nanoemulsion for brain targeting for the treatment of Parkinson's disease by reducing oxidative stress Nanotechnology 25 485102
12. Pandey Y R, Kumar S, Gupta B K, Ali J and Baboota S 2016 Intranasal delivery of paroxetine nanoemulsion via the olfactory region for the management of depression: formulation, behavioural and biochemical estimation Nanotechnology 27 025102
13. Singh S K, Dadhania P, Vuddanda P R, Jain A, Velaga S and Singh S 2016 Intranasal delivery of asenapine loaded nanostructured lipid carriers: formulation, characterization, pharmacokinetic and behavioural assessment RSC Adv. 6 2032-45
14. Liu Y, Wei F, Wang Y and Zhu G 2011 Studies on the formation of bifenthrin oil-in-water nano-emulsions prepared with mixed surfactants Colloids Surf. A 389 90-6
15. Capek I 2004 Degradation of kinetically-stable o/w emulsions Adv. Colloid Interface Sci. 107 125-55
16. Tzanavaras P D, Themelis D G, Zotou A, Stratis J and Karlberg B 2008 Optimization and validation of a dissolution test for selegiline hydrochloride tablets by a novel rapid HPLC assay using a monolithic stationary phase J. Pharm. Biomed. Anal. 46 670-5
17. Azzaro A J, Ziemniak J, Kemper E, Campbell B J and VanDenBerg C 2007 Pharmacokinetics and absolute bioavailability of selegiline following treatment of healthy subjects with the selegiline transdermal system (6 mg/24 h): a comparison with oral selegiline capsules J. Clin. Pharmacol. 47 1256-67
18. Sharma S, Sahni J K, Ali J and Baboota S 2015 Effect of high-pressure homogenization on formulation of TPGS loaded nanoemulsion of rutin - pharmacodynamic and antioxidant studies Drug Deliv. 22 541-51
19. Mahour R, Sahni J K, Sharma S, Kumar S, Ali J and Baboota S 2015 Nanoemulsion as a tool for improvement of cilostazol oral bioavailability J. Mol. Liq. 212 792-8
20. Belhaj N, Dupuis F, Arab-Tehrany E, Denis F M, Paris C, Lartaud I and Linder M 2012 Formulation, characterization and pharmacokinetic studies of coenzyme Q10 PUFA's nanoemulsions Eur. J. Pharm. Sci. 47 305-12
21. Pawar V K, Panchal S B, Singh Y, Meher J G, Sharma K, Singh P, Bora H K, Singh A, Datta D and Chourasia M K 2014 Immunotherapeutic vitamin E nanoemulsion synergies the antiproliferative activity of paclitaxel in breast cancer cells via modulating Th1 and Th2 immune response J. Control. Release 196 295-306
22. Patel R B, Patel M R, Bhatt K K and Patel B G 2013 Formulation consideration and characterization of microemulsion drug delivery system for transnasal administration of carbamazepine Bull. Fac. Pharm. Cairo. Univ. 51 243-53
23. Sharma G, Beg S, Thanki K, Katare O P, Jain S, Kohli K and Singh B 2015 Systematic development of novel cationic self-nanoemulsifying drug delivery systems of candesartan cilexetil with enhanced biopharmaceutical performance RSC Adv. 5 71500-13
24. Porras M, Solans C, Gonzalez C, Martinez A, Guinart A and Gutierrez J M 2004 Studies of formation of w/o nanoemulsions Colloids Surf. A 249 115-8
25. Uson N, Garcia M J and Solans C 2004 Formation of water-in-oil (W/O) nano-emulsions in a water/mixed non-ionic surfactant/oil systems prepared by a low-energy emulsification method Colloids Surf. A 250 415-21
26. Izquierdo P, Feng J, Esquena J, Tadros T F, Dederen J C, Garcia M J, Azemar N and Solans C 2005 The influence of surfactant mixing ratio on nano-emulsion formation by the pit method J. Colloid Interface Sci. 285 388-94
27. Duty S and Jenner P 2011 Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease Br. J. Pharmacol. 164 1357-91
28. Zheng J, Yang Z, Li X, Li L, Ma H, Wang M, Zhang H, Zhen X and Zhang X 2014 Optimization of 6-Heterocyclic-2-(1H-pyrazol-1-yl)-N-(pyridin-2- yl)pyrimidin-4-amine as potent adenosine A2A receptor antagonists for the treatment of Parkinson's disease ACS Chem. Neurosci. 5 674-82
29. Olsson M, Nikkhah G, Bentlage C and Bjorklund A 1995 Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test J. Neurosci. 15 3863-75
30. Fleming S M, Salcedo J, Fernagut P O, Rockenstein E, Masliah E, Levine M S and Chesselet M F 2004 Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein J. Neurosci. 24 9434-40
31. Meredith G E and Kang U J 2006 Behavioral models of Parkinson's disease in rodents: a new look at an old problem Mov. Disord. 21 1595-606
32. Lacatusu I, Badea N, Ovidiu O, Bojin D and Meghea A 2012 Highly antioxidant carotene-lipid nanocarriers: synthesis and antibacterial activity J. Nanopart. Res. 14 902
33. Sarkaki A, Eidypour Z, Motamedi F, Keramati K and Farbood Y 2012 Motor disturbances and thalamic electrical power of frequency bands' improve by grape seed extract in animal model of Parkinson's disease Avicenna J. Phytomed. 2 222-32
34. Yadav S, Gattacceca F, Panicucci R and Amiji M M 2015 Comparative biodistribution and pharmacokinetic analysis of cyclosporine-A in the brain upon intranasal or intravenous administration in an oil-in-water nanoemulsion formulation Mol. Pharm. 12 1523-33
35. Bazylinska U, Kulbacka J and Wilk K A 2014 Dicephalic ionic surfactants in fabrication of biocompatible nanoemulsions: Factors influencing droplet size and stability Colloids Surf. A 460 312-20
36. Bandyopadhyay S, Katare O P and Singh B 2012 Optimized self nano-emulsifying systems of ezetimibe with enhanced bioavailability potential using long chain and medium chain triglycerides Colloids Surf. B 100 50-61
37. Jain S, Jain A K, Pohekar M and Thanki K 2013 Novel self-emulsifying formulation of quercetin for improved in vivo antioxidant potential: implications for drug-induced cardiotoxicity and nephrotoxicity Free Radic Biol. Med. 65 117-30
38. Yemparala V, Damre A A, Manohar V, Singh K S, Mahajan G B, Sawant S N, Deokule T and Sivaramakrishnan H 2014 Effect of the excipient concentration on the pharmacokinetics of PM181104, a novel antimicrobial thiazolyl cyclic peptide antibiotic, following intravenous administration to mice Results Pharma. Sci. 4 34-41
39. Gonzalez N, Simarro R, Molina M C, Bautista L F, Delgado L and Villa J A 2011 Effect of surfactants on PAH biodegradation by a bacterial consortium and on the dynamics of the bacterial community during the process Bioresour. Technol. 102 9438-46
40. Singh A K, Chaurasiya A, Awasthi A, Mishra G, Asati D, Khar R K and Mukherjee R 2009 Oral bioavailability enhancement of exemestane from self-microemulsifying drug delivery system (SMEDDS) AAPS PharmSciTech. 10 906-16
41. Ghosh P K and Murthy R S 2006 Microemulsions: a potential drug delivery system Curr. Drug Deliv. 3 167-80
42. Choudhury H, Gorain B, Karmakar S, Biswas E, Dey G, Barik R, Mandal M and Pal T K 2014 Improvement of cellular uptake, in vitro antitumor activity and sustained release profile with increased bioavailability from a nanoemulsion platform Int. J. Pharm. 460 131-43
43. Polychniatou V and Tzia C 2014 Study of formulation and stability of co-surfactant free water-in-olive oil nano- and submicron emulsions with food grade non-ionic surfactants J. Am. Oil Chem. Soc. 91 79-88
44. Shah B, Khunt D, Misra M and Padh H 2016 Non-invasive intranasal delivery of quetiapine fumarate loaded microemulsion for brain targeting: formulation, physicochemical and pharmacokinetic consideration Eur. J. Pharm. Sci. 91 196-207
45. Preetz C, Hauser A, Hause G, Kramer A and Mader K 2010 Application of atomic force microscopy and ultrasonic resonator technology on nanoscale: distinction of nanoemulsions from nanocapsules Eur. J. Pharm. Sci. 39 141-51
46. Pan H, Yu L, Xu J and Sun D 2014 Preparation of highly stable concentrated w/o nanoemulsions by PIC method at elevated temperature Colloids Surf. A 447 97-102
47. Dordevic S M, Radulovic T S, Cekic N D, Randelovic D V, Savic M M, Krajisnik D R, Milic J R and Savic S D 2013 Experimental design in formulation of diazepam nanoemulsions: physicochemical and pharmacokinetic performances J. Pharm. Sci. 102 4159-72
48. Baboota S, Abdullah, Mustafa G, Sahni J K and Ali J 2013 Mechanistic approach for the development of ultrafine oil-water emulsions using monoglyceride and blends of medium and long chain triglycerides: enhancement of the solubility and bioavailability of Perphenazine J. Excipients Food Chem. 4 12-24
49. Zhang H, Yao M, Morrison R A and Chong S 2003 Commonly used surfactant, Tween 80, improves absorption of P-glycoprotein substrate, digoxin, in rats Arch. Pharm. Res. 26 768-72
50. Carillo M C, Kitani K, Kanai S, Sato Y, Miyasaka K and Ivy G O 1994 (-)Deprenyl increases activities of superoxide dismutase and catalase in certain brain regions in old male mice Life Sci. 54 975-81
51. Farias C C, Bonifacio K L, Matsumoto A K, Higachi L, Casagrande R, Moreira E G and Barbosa D S 2014 Comparison of the antioxidant potential of antiparkinsonian drugs in different in vitro models Braz. J. Pharm. Sci. 50 819-826